12/2
08:04 am
upb
Upstream Bio (NASDAQ:UPB) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $43.00 price target on the stock.
High
Report
Upstream Bio (NASDAQ:UPB) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $43.00 price target on the stock.
11/25
11:55 pm
upb
Upstream Bio (UPB): Evaluating Valuation After 10% Share Price Surge [Yahoo! Finance]
Low
Report
Upstream Bio (UPB): Evaluating Valuation After 10% Share Price Surge [Yahoo! Finance]
11/25
08:01 am
upb
Upstream Bio to Participate in Upcoming December Investor Conferences [Yahoo! Finance]
Medium
Report
Upstream Bio to Participate in Upcoming December Investor Conferences [Yahoo! Finance]
11/25
07:00 am
upb
Upstream Bio to Participate in Upcoming December Investor Conferences
High
Report
Upstream Bio to Participate in Upcoming December Investor Conferences
11/5
07:00 am
upb
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress
Medium
Report
Upstream Bio Reports Third Quarter 2025 Financial Results and Highlights Continued Progress
10/31
07:00 am
upb
Upstream Bio to Participate in Upcoming November Investor Conferences
Low
Report
Upstream Bio to Participate in Upcoming November Investor Conferences
10/16
04:59 pm
upb
Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting [Yahoo! Finance]
Medium
Report
Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting [Yahoo! Finance]
10/16
06:39 am
upb
Upstream Bio (NASDAQ:UPB) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Low
Report
Upstream Bio (NASDAQ:UPB) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
10/14
07:00 am
upb
Upstream Bio (NASDAQ:UPB) was given a new $47.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Upstream Bio (NASDAQ:UPB) was given a new $47.00 price target on by analysts at Truist Financial Corporation.
10/4
10:45 am
upb
Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past Week [Yahoo! Finance]
Low
Report
Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past Week [Yahoo! Finance]
9/30
06:22 am
upb
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug's Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress [Yahoo! Finance]
Medium
Report
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug's Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress [Yahoo! Finance]
9/30
04:15 am
upb
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress
Medium
Report
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress
9/9
07:37 am
upb
Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum [Yahoo! Finance]
Low
Report
Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum [Yahoo! Finance]
9/9
07:00 am
upb
Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
Low
Report
Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
9/7
10:27 pm
upb
Upstream Bio, Inc. - Special Call [Seeking Alpha]
Medium
Report
Upstream Bio, Inc. - Special Call [Seeking Alpha]